Skip to content

Colorectal Cancer Health Center

Font Size

Significance

    Colorectal cancer (CRC) is the third most common malignant neoplasm worldwide [1] and the second leading cause of cancer deaths in the United States.[2] It is estimated that there will be 142,820 new cases diagnosed in the United States in 2013 and 50,830 deaths due to this disease. From 2005 to 2009, CRC incidence declined by 4.1% per year among adults aged 50 years and older. However, in adults younger than 50 years, CRC incidence rates have been increasing by 1.1% per year. From 2005 to 2009, mortality from CRC declined by 2.4% per year in men and 3.1% per year in women.[2] The incidence is higher in men than in women. It ranges from 46.1 per 100,000 per year in Hispanic men to 66.9 per 100,000 per year in African American men. In women it ranges from 31.9 per 100,000 per year in Hispanics to 50.3 per 100,000 per year in African Americans.[3] The age-adjusted mortality rates for men and women are 20.2 per 100,000 per year in men and 14.1 per 100,000 per year in women.[3] About 5% of Americans are expected to develop the disease within their lifetime and about half of those will die from it.[3] Age-specific incidence and mortality rates show that the vast majority of cases are diagnosed after age 50 years; about 4% of CRCs occur younger than age 50 years.[3,4]

    Among the groups that have a high incidence of CRC are those with hereditary conditions, such as familial adenomatous polyposis and hereditary nonpolyposis CRC (inherited in an autosomal dominant manner). Combined, the two groups account for no more than 6% of CRCs. More common conditions associated with an increased risk include a personal history of CRC or adenomas; first-degree relative with CRC; a personal history of ovarian, endometrial, or breast cancer; and a personal history of long-standing chronic ulcerative colitis or Crohn colitis.[5,6,7] These high-risk groups account for about a quarter of all CRCs. Limiting screening or early cancer detection to only these high-risk groups would miss the majority of CRCs.[8]

    Recommended Related to Colorectal Cancer

    Stage IV and Recurrent Rectal Cancer

    Treatment options for local control: Resection of locally recurrent rectal cancer may be curative in selected patients.[1] Palliative surgical resection with either low-anterior resection (LAR) or abdominoperineal resection (APR).[1] Palliative radiation therapy.[2,3] Palliative chemotherapy.[4,5,6,7,8,9,10] Palliative chemoradiation.[11,12] Chemotherapy alone for local control. Palliative, endoscopic-placed stents to relieve obstruction.[13] Treatment options...

    Read the Stage IV and Recurrent Rectal Cancer article > >

      1|2

      Today on WebMD

      Colorectal cancer cells
      The right diagnosis is the most important factor.
      man with a doctor
      Our health check will steer you in the right direction.
       
      sauteed cherry tomatoes
      Fight cancer one plate at a time.
      bladder cancer x-ray
      Do you know the warning signs?
       
      bread
      ARTICLE
      Colon vs Rectal Cancer
      VIDEO
       
      New Colorectal Treatments
      VIDEO
      can lack of sleep affect your immune system
      FEATURE
       
      Cancer Facts Quiz
      QUIZ
      Virtual Colonoscopy
      VIDEO
       
      Picture of the Colon
      ANATOMY
      Vitamin D
      SLIDESHOW
       

      WebMD Special Sections